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DISSECTION OF THE HORMETIC CURVE: ANALYSIS OF COMPONENTS AND
MECHANISMS

Volodymyr I. Lushchak 䊐 Department of Biochemistry and Biotechnology, Vassyl
Stefanyk Precarpathian National University, 57 Shevchenko Str., Ivano-Frankivsk,
76025, Ukraine
䊐 The relationship between the dose of an effector and the biological response frequently is not described by a linear function and, moreover, in some cases the doseresponse relationship may change from positive/adverse to adverse/positive with increasing dose. This complicated relationship is called “hormesis”. This paper provides a short
analysis of the concept along with a description of used approaches to characterize
hormetic relationships. The whole hormetic curve can be divided into three zones: I – a
lag-zone where no changes are observed with increasing dose; II – a zone where beneficial/adverse effects are observed, and III – a zone where the effects are opposite to those
seen in zone II. Some approaches are proposed to analyze the molecular components
involved in the development of the hormetic character of dose-response relationships with
the use of specific genetic lines or inhibitors of regulatory pathways. The discussion is then
extended to suggest a new parameter (half-width of the hormetic curve at zone II) for
quantitative characterization of the hormetic curve. The problems limiting progress in the
development of the hormesis concept such as low reproducibility and predictability may
be solved, at least partly, by deciphering the molecular mechanisms underlying the
hormetic dose-effect relationship.
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“That which does not kill us makes us stronger.”
Friedrich Nietzche, German philosopher, XIX century.
INTRODUCTION

The relationship between the dose of an effector and the biological
response that it elicits is a cornerstone of basic and applied disciplines of
physiology, biochemistry, toxicology and pharmacology; indeed, its
importance is illustrated by the existence of specialized scientific journal
dedicated to this phenomenon (Dose-Response, http://www.doseresponse.com). Two models of dose-response relationships are commonly used (Calabrese et al. 1987; Calabrese and Baldwin 1998; Calabrese
2008, 2013a, b; Gaman et al. 2011; Ristow and Schmeisser 2011; Cox 2012;
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Deng et al. 2012; López-Martínez and Hahn 2012; Calabrese et al. 2012;
Demirovic and Rattan 2013). In the first one, called the linear model, the
registered endpoint shows a linear dependence on the dose of the effector (Figure 1A); this is also called the linear non-threshold model
(Hadley 2003). The α-angle can vary widely and depends on many factors
including the model type, specific conditions used and the properties of
effectors. It is based on cumulative effects of single acts of interaction
between the effector and the biological subject. However, in many cases
the response cannot be linearly extrapolated to “zero” dose. In these
cases, the observed effects may only begin to be observed from a certain
(threshold) dose (X = A) with different distances from the beginning of
the abscissa (X = 0) (Figure 1B). This relationship is called the “threshold model”. The distance “a” seen in Figure 1B is called the “lag phase”

FIGURE 1. Dose-response relationships: (A) the linear model, (B) the threshold (linear) model, (C)
the J-shaped model, and (D) the inverted U-shaped model, or inverted J-shaped model. The dashed
line shows initial level of the response being measured (endpoint). Description in the text.
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and may reflect the operation of defense mechanisms that prevent an
immediate response by organisms.
The theoretical material presented above may be illustrated by the
examples on the effects of reactive oxygen species (ROS) on biological
systems (Lushchak 2011). In order to evaluate the antioxidant capacity of
an organism, it is usually necessary to challenge the organism with oxidants at certain doses (concentrations). Endogenous antioxidants can
prevent oxidation of molecular targets, but when a certain dose of oxidant is reached, the antioxidant potential will be exceeded and oxidative
damage will take place. In this case, the situation demonstrates a threshold character as seen in Figure 1B where “a” represents the capacity of the
system to tolerate changes provoked by inducers. Similar to the situation
described for Figure 1A, the α-angle is again variable. However, in many
cases the dose-response relationship at low doses does not follow either
the linear (Figure 1A) or the threshold (Figure 1B) model. Rather, it
shows changes in opposite directions over zones of low and high doses.
These relationships where low doses of an effector trigger responses
opposite to high ones are called “hormetic”, from the Greek hórm?sis
meaning “rapid motion, eagerness” (or the ancient Greek hormáein “to
set in motion, impel, urge on”). Two main types of these dependences
have been described. One is called J-shaped (Figure 1C) and the other is
inversed U-shaped (Figure 1D) (Hadley 2003; Cook and Calabrese 2006;
Calabrese 2008). The inversed U-shaped hormetic relationship might be
more correctly named inversed J-shaped, because it is asymmetric and is
cut off at the “zero” point of the abscissa. Actually, it does not matter very
much how it is called, as long as we clearly recognize the character of the
relationship.
Although the hormetic relationship was first described more than a
century ago (Schulz 1888, cited after Calabrese and Baldwin 1998), for
various reasons it was largely ignored until about the last decade when it
was analyzed in detail by E. Calabrese and colleagues. Previously, we have
not mentioned which type of effector induces a certain type of hormetic
response, or what was used as the “endpoint” or biological effect. This is
because there are huge numbers of possibilities. The effector could be
either chemical or physical in nature (e.g. different compounds, temperature, physical exercise, radiation, light, etc.) whereas the endpoint may
be virtually any biologically important parameter including survival time,
fecundity, organism mass and length, stress resistance, blood pressure,
enzyme activity, protein levels, fuel reserves, etc. Depending on the endpoint selected, dose-response curves can differ for the same organism or
under the same conditions.
In the present paper, I do not investigate the details of the effectorendpoint relationship in different systems. There are excellent, detailed
and readily available publications on this topic by the research groups of
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E. Calabrese (Calabrese and Baldwin 1998; Calabrese 2008), S. Rattan
(Rattan and Demirovic 2009; Rattan 2012; Demirovic and Rattan 2013),
E. le Bourg (Le Bourg 2009; Le Bourg and Rattan 2009), L. Partridge
(Gems and Partridge 2008) as well by others (Radak et al. 2005; Birringer
2011; Brigelius-Flohé and Flohé 2011; Pijl 2012). Instead, my analysis
focuses on just one of the hormetic relationships, the case of the inversed
J-shape (Figure 1D), the most frequently found relationship in biological
systems. This relationship shows that, at low doses, effectors enhance the
response parameter, but with an increase in effector dose the effect
becomes less pronounced until no further increment in effect is found,
and finally the parameter of interest begins to decrease back to the initial
(control) level or to an even lower value. This paper aims to analyze the
main parameters involved in causing the inverted J-shape relationship in
order to propose some clues for its quantitative characterization.
1. “CLASSIC” DESCRIPTION OF THE HORMETIC CURVE

To develop some system and objectivity in hormesis research, E.
Calabrese and L. Baldwin (1998) used specific criteria to create a database of articles related to the problem. For that, they analyzed approximately 8000 dose-response studies taking into account such criteria as the
strength of the study, design features, magnitude of the low dose stimulation, statistical significance, and reproducibility of the findings. Usually
the hormetic dose-response is supposed to be reliably described as stimulation in the low dose zone, followed by inhibition at high doses
(Calabrese 2008). The typical stimulatory effect reaches about 30-60%
above the control level and in most cases the maximum stimulatory
response was less than twice the control value (Figure 2). Furthermore,
in most cases, the zero equivalent point (ZEP; where the response
changes from stimulation to inhibition) was reached within a 100-fold
increase in dose (Calabrese 2008). However, in some cases, a very broad
stimulatory range exceeding 1000-fold was found. The stimulatory range
causing expected (positive medical effect) is usually defined as a therapeutic window. However, in some cases the effects of low doses may be
deleterious like in example where antitumor drugs stimulate tumor
growth at low doses and only high doses inhibit it (cited after Calabrese
2005). Calabrese (2008) stated that “the hormetic stimulatory zone is
graphically contiguous with the pharmacologic/toxicologic threshold”.
Inter-individual variation may complicate the use of hormetic-based therapies due to the possibility of the desired therapeutic dose being a toxic
dose to some individuals. This variation must be taken into account and
corrected by monitoring specific parameters.
The point where an effector-induced positive (or negative) effect of a
treatment reverses itself is a cornerstone of the hormetic hypothesis. The
two ranges of doses/concentrations meet at specific point where no effect
469
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FIGURE 2. “Classic” presentation of the dose-response hormetic curve. Abbreviations used: NOAEL
– no observable adverse effect level – the dose of inducer where no observable effect is seen; ZEP –
zero equivalent point. Description in the text.

is observed and this point is commonly known as the “no observable
adverse effect level” (NOAEL), a term commonly used in medicine. The
NOAEL is also applicable to analysis of hormetic curves (Figure 2).
The information given in this section above is a short description of
the hormetic hypothesis extensively propagated by E. Calabrese and colleagues. This hypothesis may be very productive not only due to its application to basic science interests, but also due to numerous applications to
adaptation studies and pharmaceutical research. However, the concept
has also been subjected to serious critique (Thayer et al. 2005) which may
further simulate its development. In addition, the concept may be actively applied to “classic” toxicology and therapy.
To my mind, the first and the most attractive thing about the hormesis concept is its potential possibilities for use in analyzing the ability of
organisms to adapt to adverse effectors via stimulation of endogenous
protective systems. The second important issue involves the concept that
low or very low doses of effectors may induce less adverse effects or sideeffects than “classically” used doses in “official” medicine thereby potentially minimizing the development of various pathologies and even fatalities. These points are related to the Hippocratic Oath “I will prescribe
treatment to the best of my ability and my judgment for the good of the
sick and never for harmful or illicit purpose”.

470

Published by ScholarWorks@UMass Amherst, 2014

5

Dose-Response: An International Journal, Vol. 12 [2014], Iss. 3, Art. 9

Hormetic curve analysis

2. “IDEALIZED” HORMETIC CURVES AND THEIR COMPONENTS

From a theoretical point of view, the hormetic curve consists of a minimum of two components. The negative inhibitory effect of the inducer
(Figure 3A, line 2) occurs at all doses applied, but at low doses it is negligible and masked by the activatory effect. When the two processes – inhibition and activation – are superimposed, the net effect on the response
parameter (endpoint) being monitored as it is depicted by curve 1
(Figure 3A). Although the effector is the same for both processes mentioned – inhibition and activation – and basic chemical mechanisms of
the effects caused may be potentially similar, the primary targets or modified molecules usually differ. The exponentially declining component

FIGURE 3. Two- (A) and three-component (B) curves demonstrating the components contributing
to the total hormetic curve. Curve 1 – general hormetic dose-response; 2 – pure negative effects of
the effector, and 3 – negative (suppressive) effects in the presence of operating defense mechanisms.
Description in the text.
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represents one or several target systems critically important for the development of the registered endpoint. In the simplest case, the process is
described by a first order (or pseudo-first order) declining exponential
function (Figure 3A, curve 2). Depending on the nature of the selected
endpoint, the curve may or may not approach zero. The second process
is related to the increase in defense potential induced by the same effector. Again, either one or more systems can be involved, but to simplify the
analysis an idealized dose-response curve can be envisioned that deals
with only one system. So, the system is initially activated and to a certain
extent may increase tolerance leading to an observation of improved
function. However, higher doses of the effector also may inactivate regulatory pathways responsible for enhancing function, thereby leading to a
decrease or disappearance of the observed system activation and a
decline in the registered response parameter.
Living organisms possess defense systems to prevent their injury by
many factors. Therefore, the two-component system described above
does not often match the real response in nature. The defense systems
also contribute to the net hormetic response observed with increasing
dose of the inducer. At very low effector doses, a defense system successfully prevents injury and, hence, no observable effects occur. When the
threshold of the activatory system (responsible for the upregulation of
defense mechanisms) is reached, a researcher may observe an increased
response to the dose followed by the well-known hormetic curve (Figure
3B, line 1). Now let us analyze the components that provide this “idealized” hormetic curve (Figure 3B). From basic logic and data from many
experiments, the damage component described above by a first order
declining curve always exists (Figure 3B, line 2). Since the defense system
can, to a large extent, prevent damage to the critically important endpoint parameter, line 3 demonstrates the idealized relationship connecting the response registered with the dose applied, under conditions
where a defense system virtually does not operate. Curve 3 in Figure 3B
shows the superposition of damaging effects of the effector and protective system(s) defending the organism against the deleterious effects of
the effector. In my opinion, this three-component system (Figure 3B)
describes the dose-response relationship in most cases. It is clear that the
real situation in living organisms may be much more complicated and the
net response probably includes many other components. However, in
radiobiology, for example, it is accepted that in certain cases one system
is the critically important target affected by radiation and most of the registered biological responses depend on that system (Greenberger et al.
2003). In hormesis, the situation also may be similar and the question
raised will be covered below.
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3. EXPERIMENTAL AND MATHEMATICAL APPROACHES TO ANALYZE THE
HORMETIC CURVE

Analysis of many thousands of hormetic curves was carried out by
Calabrese and colleagues (Calabrese and Baldwin 1998, 2001; Calabrese
and Blain 2011). In the present work, I would like to demonstrate potential approaches to analyze the components responsible for the formation
of the complicated dose-response relationships that are observed.
Interested readers can find more information on this topic in review articles (Hadley 2003; Calabrese 2008) and the references therein on earlier
model studies such as the interaction of two functionally antagonistic
receptor populations activated by the same agonist (Szabadi 1977) or the
regulation of G-protein coupled receptors by agonists and antagonists
(Järv 1995).
To make analysis easier, we will start with the two-component system
(Figure 3A). How can the researcher discriminate experimentally
between the two processes involved – activatory and inhibitory? An appropriate way to begin would be to block the process of activation of defense
systems and then analyze the inactivation process. There are at least two
potential approaches to do that. One of them is to disrupt potential pathways responsible for the activation process. Theoretically, if the function
can be switched off without lethal consequences, it should be possible to
inactivate the adaptive activation response pathway at the level of receptors, transmitters, target systems, etc. Nowadays, there are many experimental approaches to construct organisms with genetically inactivated
regulatory pathways. For example, it is well known that in baker’s yeast,
the Yap1 protein regulates the transcription of genes involved in the
response to reactive oxygen species (ROS), such as hydrogen peroxide
(Semchyshyn 2009; Lushchak 2010; Semchyshyn and Lozinska 2012). In
the yeast strain with a defective YAP1 gene, the cells adapt to increased
H2O2 levels very poorly and, as a result, they are more sensitive to this toxicant. My laboratory (Bayliak et al. 2006) and others (Stephen et al. 1995)
found that in response to incubation with low H2O2 concentrations yeast
mutants with a defective YAP1 gene did not increase tolerance to H2O2,
whereas the “wild” strain showed increased tolerance and enhanced viability. Similarly, the involvement of YAP1 protein in the adaptive response
of yeast to nitric oxide exposure was also reported (Lushchak et al. 2010).
Recently, two stress-regulated systems, involving the regulatory proteins
Yap1 and Msn2/4, were shown to be responsible for the hormetic yeast
response to different concentrations of a preparation of the medicinal
herb Rhodiola rosea (Bayliak et al. 2013). In general, then, if an organism
can be engineered to switch off the systems responsible for the activation
of defense mechanisms against a toxicant or physical stressor, one could
produce an organism that would not be able to develop the hormetic
response (or at least not the full response).
473
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The second experimental approach that could be used to dissect the
components responsible for an observed hormetic dose-response curve
would be to inhibit protein or mRNA biosynthesis or other processes
directly or indirectly responsible for the increase in tolerance. Again, it is
relatively easy to apply this approach to cell cultures or unicellular organisms like bacteria or yeast, but with multicellular organisms the situation
is much more complicated. Although two-component hormetic curves
may be more the exception than the rule, this simplified model may help
us to clearly understand the processes involved and identify potential
experimental approaches. It is also supported by the understanding that
in many cases mostly one system is critically important to provide endpoint response to effector exposure. I mean here that one may approximate the resulting action to effects on one organ that is critically important for surviving under the specific condition. For example, in many
cases where exposure to toxicants occurs, it is the liver or kidney that may
be the primary target, whereas brain and heart are well protected and
would not be substantially affected.
Now the question arises: how can we derive quantitative parameters of
the involvement of processes that result in a hormetic dose-response relationship? As mentioned above, it is sometimes possible to experimentally
inactivate the system(s) responsible for the development of the hormetic
relationship. This inactivation may be accomplished either via the use
specific gene deletion strains or by inhibiting protein or mRNA synthesis
to get a dose-response curve without an activation component, i.e. producing only the declining (inhibitory) curve. In the control condition,
however, the system provides the full hormetic curve. The results from
these two conditions (control vs inactivated) can be superimposed, as
seen in the two-component system (Figure 3A, curve 1 vs 2). Subtraction
of the values of curve 2 from those of curve 1 therefore shows the contribution of the activation of defense systems to the total hormetic function
(shaded area). To some extent, a similar analysis can be carried out even
without manipulation with the systems responsible for adaptation, but
this can be less accurate. By analogy to many biological and chemical
processes, one may assume that at the far right-hand side of the hormetic curve (Figure 3A), the response is purely an inhibitory one and follows
a first order dependency. Using this part of the total curve, it is therefore
possible to get parameters for the needed equation by taking into
account the “zero” dose point, i.e. extrapolate the right-hand portion of
the curve to the ordinate at X = 0. It is clear that too many factors should
be ignored or approximated by this method, but in this way we can quantitatively analyze the role of certain components of the total doseresponse relationship.
As with the “idealized” two-component system, we can apply similar
logic to analyzing a three-component system (Figure 3B). The first order
474
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decline function is also present here (Figure 3B curve 2). However, the
operation of protective mechanisms does not let us observe the negative
effects neutralizing them. Therefore, a lag-phase may be identified and,
furthermore, at higher doses of the effector, curve 3 may virtually merge
with curve 2. Of course, curve 1 describes the overall process. It is potentially possible to determine curve 3 (Figure 3B) experimentally using specific genetic constructs or inhibitors of processes leading to enhanced
resistance, as it was described above for the two-component system.
After analysis of the overall hormetic curve, some quantitative
approaches can be used to describe this curve using mathematical tools.
4. QUANTITATIVE CHARACTERISTICS OF THE HORMETIC CURVE

In this section again we will deal with the approximated “idealized”
hormetic dose-response relationship for a two-component system (Figure
3A), but for convenience this figure is redrawn to show specific features
needed for the analysis (Figure 4). The whole hormetic curve may be
divided into three zones: I – the lag-zone where no observable changes
occur; II – the zone where beneficial/adverse effects are observable, and
III – the zone where the effects observed at zone II are reversed.
Previously developed approaches (Hadley 2003; Calabrese 2008) are discussed along with the introduction of additional characteristics.
Zone I, where no observable effects are registered, is typically rather
narrow relative to the broader zones II and III. It is supposed that tradi-

FIGURE 4. “Idealized” hormetic curve to depict quantitative features of the hormetic relationship.
Zones described are: I – lag zone – no observable effects at low effector doses, II – zone of beneficial/adverse effects, III – zone of changes opposite to zone II – zone of adverse/beneficial effects.
Description in the text.
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tional approaches to evaluate the effects of interest in zone I are rather
weak (below sensitivity level). In this case, the range of doses which are
not sensed (or perhaps more correctly – where the effects are not registered due to sensitivity limits of traditionally used approaches) cannot be
defined accurately, and only the border of zone II may be used to determine its right-hand position. Zone II represents the range of doses that
constitute the “hormetic zone” (Calabrese 2008), i.e., where increases or
decreases in the parameter of interest occur. This zone is located between
zone I (lag zone) and the NOAEL point – i.e. the dose where no observable effect is found. Two characteristics of this zone are generally discussed in the literature – its width and maximum response. Since these
two characteristics do not provide information on the parameters of
steepness (slope) of the curve, I propose to add one more characteristic
– the half-width, defined as the width at the point of half-maximum
response. The NOAEL point is not ideal for characterizing the hormetic
curve, but it can be used to define the upper limit on the zone where the
effects of interest are observed.
Zone III, in my opinion, should be described differently from the
“classic” presentation of the hormetic curve. It is important to note here
that zone III typically strongly approximates a first order exponential
decay curve at highest doses of the inducer (the right-hand portion).
Depending on the endpoint, system used and many other factors, this
part of the hormetic curve tends to asymptote – either to zero at the ordinate axis (Y = 0), or to a certain asymptote (Y = A) reflecting minimum
function. This lowest part of the hormetic curve can be used to calculate
parameters of an exponential decay curve with extrapolation to the place
where the ordinate value crosses the ZEP (Y value at X = 0).
The approach described above extends the number of parameters
that can be used to provide a quantitative description of the hormetic
curve (Figure 4). After calculation of the asymptote, i.e. either the minimum value or zero on the Y-axis, it is then possible to calculate the area
under the hormetic curve 1. Similarly, the area under curve 2 can be calculated and used to characterize the adverse effects of the effector.
Finally, subtracting the area under curve 2 from the area under the
hormetic curve 1 provides a measure of the activation characteristics.
These characteristics include both the preexisting defense potential and
the defense potential induced by the effector.
In summary, then, a variety number of parameters can potentially be
calculated to provide a highly detailed description of the hormetic doseresponse relationship (Figure 4). These include the maximum response,
hormetic range, half-width range, and NOAEL, minimum (asymptote)
level, the areas under curves 1 and 2 and the defense potential (area 1
minus area 2).
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5. PROBLEMS AND PERSPECTIVES

It is clear that the hormesis concept provides many important clues to
diverse basic and applied fields of biology, toxicology and medicine. The
main problems related to the concept still remain in the low reproducibility of the results and their low predictability. The observed effects
often depend on many parameters particularly on the physiological state
of the organisms. Several aspects need special attention in this field to
make it more reliable. First, the molecular mechanisms underlying the
hormetic dose-effect relationship should be delineated in different
organisms and tissues, because it is absolutely clear now that they differ.
This approach may provide clues to make the concept more evidencebased. Second, although there are already some mathematical approaches used to characterize hormetic curves (Belz and Piepho 2012), more
accurate tools are needed. Third, in some cases, triphasic dose-response
relationships were found (Imlay and Linn 1986; Choi et al. 2012;
Semchyshyn 2014), which will need clarification to determine if they are
special cases of “typical” hormetic curves, or if hormetic curves at low
dose ranges may include one more component usually missed or overlooked for different reasons.
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